ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
AI In Clinical Research: Now And Beyond
In this piece from Forbes, Dr. Greg Licholai, Chief Medical and Chief Innovation Officer talks about the promising future of AI in clinical research.
ICON interview: Insights on the new EMA guidelines for computerised systems and electronic data in clinical trials
Vesta Marciulioniene shares her insights on the new EMA guideline for computerised systems and electronic data in clinical trials.
ICON partners with US Government for clinical trials of Covid-19 vaccines
The article reports that ICON will conduct a phase 2b clinical trial for the US BARDA-selected Covid-19 vaccine candidate as part of Project NextGen.
BARDA, ICON partner to execute next-gen COVID vaccine trial
This news article reports that ICON will execute a Phase 2b clinical trial to assess the relative efficacy of a next generation COVID-19 vaccine.
ICON in pact with BARDA for next-gen COVID vaccine trial
The piece from Seeking Alpha highlights that the trial is designed to evaluate the vaccine candidate selected by BARDA.
ICON to partner with US government agency to test COVID vaccine candidates
This news article outlines that ICON will conduct a mid-stage trial involving 10,000 participants to assess the efficacy of a next-generation COVID-19 vaccine.
ICON to conduct U.S. government trial of next-gen COVID-19 vaccines
This news article highlights that ICON is partnering with BARDA to conduct a clinical trial to evaluate next-generation vaccines for COVID-19.
Improving health equity and diversity throughout the life sciences
In this article, Joshua Bueller describes ways in which pharma companies can gain a better understanding into the needs of underrepresented and underserved groups.
Why pursuit of meaningful Alzheimer’s therapies is gathering pace
In this article in Neuro Rehab Times, ICON expert, Peter Schüler, reflects on the potential implications of new Alzheimer’s therapies on the research landscape.
AI is game changer for toughest areas of drug discovery
In this piece from Forbes, Dr. Greg Licholai, talks about how, with proper use, AI can help accelerate a new era of medical research.